The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome
about
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome populationDissociation of Down syndrome and Alzheimer's disease effects with imaging.Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatmentsCerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome.A Review of Biomarkers for Alzheimer's Disease in Down SyndromeCognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.Outcome Measures for Clinical Trials in Down Syndrome.A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.Increased levels of plasma total tau in adult Down syndrome.Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.Down syndrome, beta-amyloid and neuroimaging.Solvation-Guided Design of Fluorescent Probes for Discrimination of Amyloids.A longitudinal study of brain anatomy changes preceding dementia in Down syndrome.Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.
P2860
Q33753393-17D6808D-3DAB-48BD-A510-58B33F3FE29DQ33816076-470449DB-6DBA-4E12-ADA3-483971470A4CQ37730984-BCB82A94-C3F6-4A1A-9CF3-B62E063B895DQ37741452-3D1E589E-E35A-4CC6-922D-528E141B6D56Q38653406-7D05294B-DC31-48ED-B098-183A62F07344Q38675507-AA5E7B53-B5AA-43C6-BCC3-CB5113AC0D7AQ39091275-1E2B4761-9BED-4497-B36A-FC7F5DEDE64CQ39269317-71517F9B-2BC8-403C-A1E2-AC97E5A454A2Q46267648-9B10CE68-CD25-4CDC-B5C3-6ED781A8F109Q46566966-D918F49F-F0CF-4D77-95E7-0CADC36F05A0Q46629626-3D2A5E88-6656-4A77-825A-F64D91C35C72Q46830566-4FE57350-87D8-4326-B2C8-867F66EA2C91Q47143134-ADBBC985-B585-4C9B-AADB-9B9864D74121Q47280353-8AF1183E-5369-488E-A28E-D33F8275A5CBQ48102481-9E04CE5E-AC35-4F00-94E0-F8884E8FB883Q55053546-25B65BC0-C625-4CD5-84B2-FCC2DEEAB6E5Q55214585-8AABC9B4-CE5C-4102-9826-65CBFC9FE34FQ55443889-7851376C-6B28-44A4-91DA-4FD0414CBDA9
P2860
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The down syndrome biomarker in ...... se biomarkers in down syndrome
@ast
The down syndrome biomarker in ...... se biomarkers in down syndrome
@en
type
label
The down syndrome biomarker in ...... se biomarkers in down syndrome
@ast
The down syndrome biomarker in ...... se biomarkers in down syndrome
@en
prefLabel
The down syndrome biomarker in ...... se biomarkers in down syndrome
@ast
The down syndrome biomarker in ...... se biomarkers in down syndrome
@en
P2093
P2860
P356
P1476
The down syndrome biomarker in ...... se biomarkers in down syndrome
@en
P2093
Hannah Wishnek
James B Brewer
Michael C Donohue
Michael S Rafii
Robert A Rissman
William C Mobley
P2860
P356
10.3389/FNBEH.2015.00239
P577
2015-09-14T00:00:00Z